GeneMatrix Inc. (KOSDAQ: A109820)
Health Care · Biotechnology · KR
₩1,549.00
-9.94% today · -40.0% 1Y
GeneMatrix Inc. (KOSDAQ: A109820) operates in the Biotechnology industry within the Health Care sector. The company is valued at $23.69M.
Over the last twelve months the share price has lost 40.0%, trading between 1.20K and 2.79K.
Tweenvest scores GeneMatrix Inc. across four factors: quality 64/100, value 40/100, growth 0/100. Its strongest factor is quality.
A109820 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $23.69M
- Revenue (TTM)
- $3.94M
- P/E
- —
- EPS
- -123.85
- Dividend yield
- —
- Beta (5Y)
- 1.04
- 52-week high
- ₩2,795.00
- 52-week low
- ₩1,201.00
- Avg volume (3M)
- —
- Shares outstanding
- 20.39M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc.NasdaqCM: SHPH | $24.20M | $5.08 | -4.69% |
| Eutilex.Co.,LtdKOSDAQ: A263050 | $24.14M | ₩— | — |
| ABVC BioPharma, Inc.NasdaqCM: ABVC | $23.80M | $0.92 | -8.21% |
| Xbrane Biopharma AB (publ)OM: XBRANE | $23.72M | Skr11.40 | -18.28% |
| Transgenic Group Inc.TSE: 2342 | $23.63M | ¥224.00 | -4.27% |
| Evaxion A/SNasdaqCM: EVAX | $23.60M | $2.83 | -7.82% |
| RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.IBSE: RTALB | $23.42M | TL2.32 | -10.77% |
| BeyondSpring Inc.NasdaqCM: BYSI | $22.99M | $0.56 | -7.66% |
Figures last refreshed Oct 18, 2026.